Renal uptake of the antiapoptotic protein survivin is mediated by megalin at the apical membrane of the proximal tubule.

The inhibitor of apoptosis protein survivin is a bifunctional molecule that regulates cellular division and survival. We have previously shown that survivin protein can be found at high concentrations in the adult kidney, particularly in the proximal tubules. Here, survivin is localized primarily at the apical membrane, a pattern that may indicate absorption of the protein. Several proteins in primary urine are internalized by megalin, an endocytosis receptor, which is in principle found in the same localization as survivin. Immunolabeling for survivin in different species confirmed survivin signal localizing to the apical membrane of the proximal tubule. Immunoelectron microscopy also showed apical localization of survivin in human kidneys. Furthermore, in polarized human primary tubular cells endogenous as well as external recombinant survivin is stored in the apical region of the cells. Costaining of survivin and megalin by immunohistochemistry and immunoelectron microscopy confirmed colocalization. Finally, by surface plasmon resonance we were able to demonstrate that survivin binds megalin and cubilin and that megalin knockout mice lose survivin through the urine. Survivin accumulates at the apical membrane of the renal tubule by reuptake, which is achieved by the endocytic receptor megalin, collaborating with cubilin. For this to occur, survivin will have to circulate in the blood and be filtered into the primary urine. It is not known at this stage what the functional role of tubular survivin is. However, a small number of experimental and clinical reports implicate that renal survivin is important for functional integrity of the kidney.

[1]  P. Verroust,et al.  Renal phenotypic investigations of megalin-deficient patients: novel insights into tubular proteinuria and albumin filtration. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  G. Giaccone,et al.  A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Ling Wang,et al.  The role of survivin in diagnosis, prognosis and treatment of breast cancer. , 2011, Journal of thoracic disease.

[4]  P. Verroust,et al.  Mouse model of proximal tubule endocytic dysfunction. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  D. Talbot,et al.  Association of long-term administration of the survivin mRNA-targeted antisense oligonucleotide LY2181308 with reversible kidney injury in a patient with metastatic melanoma. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  John Kirkwood,et al.  A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma , 2011, Investigational New Drugs.

[7]  D. Altieri Survivin and IAP proteins in cell-death mechanisms. , 2010, The Biochemical journal.

[8]  K. Ahn,et al.  Increased Extracellular Survivin in the Synovial Fluid of Rheumatoid Arthritis Patients: Fibroblast-like Synoviocytes as a Potential Source of Extracellular Survivin , 2010, Inflammation.

[9]  B. Wullich,et al.  Characterization of connective tissue growth factor expression in primary cultures of human tubular epithelial cells: modulation by hypoxia. , 2010, American journal of physiology. Renal physiology.

[10]  G. Giaccone,et al.  Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  P. Verroust,et al.  Receptor-mediated endocytosis in renal proximal tubule , 2009, Pflügers Archiv - European Journal of Physiology.

[12]  M. Fukuoka,et al.  Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors , 2009, Clinical Cancer Research.

[13]  P. Lechler,et al.  The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney. , 2007, The American journal of pathology.

[14]  Dian Donnai,et al.  Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes , 2007, Nature Genetics.

[15]  A. Sanz,et al.  Targeting apoptosis in acute tubular injury. , 2003, Biochemical pharmacology.

[16]  J. Fyfe,et al.  Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D3 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Tony Hunter,et al.  Structural basis for phosphoserine-proline recognition by group IV WW domains , 2000, Nature Structural Biology.

[18]  A. Ortiz,et al.  Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. , 2000, Journal of the American Society of Nephrology : JASN.

[19]  J. Noel,et al.  Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement , 2000, Nature Structural Biology.

[20]  Henrik Vorum,et al.  An Endocytic Pathway Essential for Renal Uptake and Activation of the Steroid 25-(OH) Vitamin D3 , 1999, Cell.

[21]  Myrtle A. Davis,et al.  Review Article: Apoptosis in the Kidney , 1998, Toxicologic pathology.

[22]  S. Moestrup,et al.  beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin. , 1998, The Journal of clinical investigation.

[23]  S. Moestrup,et al.  Characterization of an Epithelial ∼460-kDa Protein That Facilitates Endocytosis of Intrinsic Factor-Vitamin B12 and Binds Receptor-associated Protein* , 1997, The Journal of Biological Chemistry.

[24]  K. Zerres,et al.  Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. , 1997, Genes & development.

[25]  D K Burns,et al.  Defective forebrain development in mice lacking gp330/megalin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T Nadasdy,et al.  Proliferative activity of intrinsic cell populations in the normal human kidney. , 1994, Journal of the American Society of Nephrology : JASN.

[27]  S. Korsmeyer,et al.  Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair , 1993, Cell.

[28]  Salma Khan,et al.  Survivin is released from cancer cells via exosomes , 2010, Apoptosis.

[29]  M. Moore Urine detection of survivin and diagnosis of bladder cancer. , 2001, Journal of insurance medicine.

[30]  E. Conway,et al.  The FASEB Journal • Research Communication Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure , 2022 .